Quantum-computing stocks may fit only investors who can tolerate substantial technical, commercialization, financing, and loss risks. A company’s disclosures cannot tell you whether any stock suits your personal circumstances. Before investing, assess your time horizon, diversification, and ability to lose the capital at risk; treat pure-play exposure as speculative rather than as a dependable way to participate in a promising technology.
What would make a quantum-computing stock a fit?
Start by separating two questions: could quantum computing become important, and can a particular company turn its approach into a durable business that rewards shareholders? A positive answer to the first does not settle the second. Even technical progress can be followed by delays, high development costs, competition, additional financing, or a stock price that does not reflect the eventual business outcome.
As an Amazon Associate I earn from qualifying purchases.
IonQ’s 2025 annual report describes the company as early-stage, says it has not produced a scalable quantum computer, and says broad quantum advantage depends on future technical milestones. Those are issuer disclosures, not an independent comparison of systems. They illustrate why a roadmap or research milestone should not be treated as proof of a scalable commercial product. IonQ’s 2025 Form 10-K
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →- Risk capacity: Could you withstand a large loss, or a long period in which a company spends heavily without establishing repeatable commercial demand?
- Time horizon: Does your investment horizon allow for uncertain development and commercialization timelines, rather than depending on near-term results?
- Portfolio role: Would exposure remain consistent with your diversification needs, instead of making your outcome depend heavily on one speculative company or technology thesis?
- Evidence standard: Are you evaluating demonstrated results and reported sales separately from targets, forecasts, customer announcements, and technical plans?
These are decision questions, not a personalized allocation rule. The disclosures cited here do not establish an appropriate purchase price, portfolio weight, or recommendation for an individual investor.
#1 Best Overall
What are the main risks of investing in quantum-computing stocks?
Technical milestones may not produce a scalable product
Quantum-computing companies may pursue different approaches and roadmaps. A technical result, patent, or planned milestone does not by itself establish a system that can be scaled, sold economically, or used repeatedly to solve valuable customer problems. IonQ says in its 2025 Form 10-K that it has not produced a scalable quantum computer and that broad quantum advantage depends on future milestones. Investors should distinguish what a company says it has demonstrated from what it hopes to achieve.
Commercial demand can be hard to read
Revenue may come from development work rather than repeatable sales of systems, hardware, or cloud access. Rigetti says the substantial majority of its current revenue comes from development contracts and expects those contracts to remain important for at least the next several years as it seeks to expand QPU, system, and cloud sales. That mix is important context when assessing whether contract revenue demonstrates a scalable commercial market. Rigetti’s 2025 Form 10-K
Rank #2
D-Wave reported more than 135 customers, including more than 70 commercial enterprises, in fiscal 2025. These are company-reported customer counts; they do not establish how much customers spent, whether use recurs, or whether the activity is profitable. D-Wave’s fiscal 2025 results announcement
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Fix the driver behind crashes, sound loss and screen glitchesFind Drivers →Losses can lead to continuing financing needs
Development costs can remain high before significant commercial revenue arrives. IonQ reported a net loss attributable to the company of $510.4 million for 2025 and an accumulated deficit of $1,194.1 million as of December 31, 2025. Its 2025 Form 10-K says it expects continuing losses and may need cash, investments, equity or debt financing, or other capital sources until it generates significant commercial revenue, if ever. These figures and statements are issuer-reported. IonQ’s 2025 Form 10-K
When a company raises equity, existing shareholders may be diluted; borrowing can add repayment obligations. The relevant question is not simply whether a company has cash today, but how its spending, business progress, future financing, and other uses of capital could affect the business and shareholders over time.
Cash does not guarantee a runway or a return
IonQ reported $130.0 million in annual revenue for 2025 and $3.3 billion in cash, cash equivalents, and investments as of December 31, 2025. Those company-reported figures should be read alongside its reported losses and its Form 10-K discussion of potential funding needs. They do not, on their own, establish a specific runway: that would require assessing spending, acquisitions, financing, and future results. IonQ’s fiscal 2025 results announcement; IonQ’s 2025 Form 10-K
Valuation and timing can overwhelm a sound technology thesis
A technology may matter while a particular stock disappoints because of valuation, dilution, execution, competition, or the time needed to commercialize it. Company filings describe businesses and risks; they do not provide a neutral comparison of system performance or establish what an investor should pay. The company figures below are not a substitute for checking current market prices, share counts, filings, and valuation assumptions.
How do the companies’ disclosed approaches and business evidence differ?
The disclosures support a comparison of what each company says about its approach and business—not a ranking of which system is technically superior or which stock is the better investment.
Best Value
| Company | Disclosed approach or status | Commercial evidence and context | What the evidence does not establish |
|---|---|---|---|
| IonQ | Its 2025 Form 10-K describes the company as early-stage and says it has not produced a scalable quantum computer. The cited disclosures do not characterize its technical approach for this comparison. | IonQ reported $130.0 million in annual revenue for 2025 in its FY2025 results announcement. The announcement’s figure is issuer-reported. | The cited facts do not establish scalable commercial use, broad quantum advantage, or a neutral performance comparison. Revenue alone does not show profitable, recurring demand. |
| Rigetti | Rigetti’s 2025 Form 10-K discusses its quantum-computing business and efforts to expand QPU, system, and cloud sales; the cited facts do not provide a neutral performance comparison against other companies. | Rigetti says the substantial majority of its current revenue comes from development contracts and expects these contracts to remain important for at least the next several years. | The contract mix does not by itself establish repeatable product demand or when other sales will become significant. |
| D-Wave | D-Wave’s 2025 Annual Report describes offerings spanning annealing and gate-model technology. | D-Wave reported more than 135 customers, including more than 70 commercial enterprises, in fiscal 2025. Its 2025 Annual Report reported more than 550 granted and pending patents worldwide as of December 31, 2025. | Customer counts do not prove recurring profitable use. The patent count is company-reported and does not independently establish patent quality, technical superiority, or a commercial moat. |
Sources: IonQ 2025 Form 10-K; IonQ FY2025 results; Rigetti 2025 Form 10-K; D-Wave FY2025 results; D-Wave 2025 Annual Report.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How should you compare quantum-computing companies?
Use the same questions for each company, and check the latest annual and quarterly filings before relying on a past result. Annual reports and SEC filings are useful for risk factors and financial statements; press-release metrics and forecasts should be labeled as company-reported rather than treated as independent validation.
- Identify the approach and the evidence. What technical approach is the company pursuing? Which milestones does it say it has demonstrated, and which remain planned? Do not treat a target or forecast as a completed result.
- Test the commercialization claim. Is the system described as scalable? What supports repeatable customer use? Separate customer counts and development contracts from evidence of recurring, profitable demand.
- Trace the revenue mix. Look for the share of revenue from development contracts, hardware or system sales, cloud access, and other activities. If a filing does not state a comparable breakdown, do not infer one from a headline revenue figure.
- Assess financial needs and shareholder impact. Review losses, cash and investments, debt, spending, and what management says about future funding. Consider whether further equity or debt could be needed and how it might affect shareholders.
- Separate issuer claims from independent evidence. Record whether customer, market, patent, and technical claims come from the company. Ask what those figures measure—and what they do not.
- Look for ways the thesis could fail. Consider technical setbacks, delayed commercialization, limited customer adoption, financing needs, competition, and a mismatch between expectations and eventual business results.
IonQ’s 2025 Form 10-K states, “Investing in our securities involves a high degree of risk.” That is the issuer’s own risk disclosure, not a prediction about the stock’s future performance. IonQ’s 2025 Form 10-K
Recommended Free Tools
What should you verify before making a decision?
- Read the company’s latest filings for changes in its technical milestones, revenue sources, losses, cash needs, and stated risks.
- Check whether customer figures refer to paid, recurring activity and whether the company reports evidence of profitable demand; do not assume a customer count answers either question.
- Compare the current share price and valuation with your own assumptions about execution and timing. The company disclosures discussed here do not establish a current stock price, valuation multiple, or appropriate portfolio weight.
- Decide whether the risk fits your personal time horizon, diversification, and ability to lose capital. No company disclosure can make that suitability decision for you.
The figures and company disclosures cited in this article relate to fiscal 2025 and the specified year-end dates. They may change as companies report later results.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
